Celon Pharma Dividend

Dividend criteria checks 0/6

Celon Pharma is a dividend paying company with a current yield of 0.6%.

Key information

0.6%

Dividend yield

-18%

Payout ratio

Industry average yield2.4%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-zł0.49
Dividend yield forecast in 3Y0.6%

Recent dividend updates

Recent updates

Earnings Update: Celon Pharma S.A. (WSE:CLN) Just Reported And Analysts Are Boosting Their Estimates

Sep 24
Earnings Update: Celon Pharma S.A. (WSE:CLN) Just Reported And Analysts Are Boosting Their Estimates

Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans

Jul 13
Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans

We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow

Nov 04
We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow

We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth

Aug 04
We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth

Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly

May 23
Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly

Calculating The Intrinsic Value Of Celon Pharma S.A. (WSE:CLN)

Mar 02
Calculating The Intrinsic Value Of Celon Pharma S.A. (WSE:CLN)

Celon Pharma S.A. (WSE:CLN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Feb 09
Celon Pharma S.A. (WSE:CLN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Celon Pharma's (WSE:CLN) Earnings Are Growing But Is There More To The Story?

Jan 20
Celon Pharma's (WSE:CLN) Earnings Are Growing But Is There More To The Story?

Celon Pharma (WSE:CLN) Shareholders Have Enjoyed A 12% Share Price Gain

Dec 24
Celon Pharma (WSE:CLN) Shareholders Have Enjoyed A 12% Share Price Gain

Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet

Dec 03
Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: CLN is not paying a notable dividend for the Polish market, therefore no need to check if payments are stable.

Growing Dividend: CLN is not paying a notable dividend for the Polish market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Celon Pharma Dividend Yield vs Market
How does CLN dividend yield compare to the market?
SegmentDividend Yield
Company (CLN)0.6%
Market Bottom 25% (PL)2.4%
Market Top 25% (PL)7.9%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast in 3 Years (CLN)0.6%

Notable Dividend: CLN's dividend (0.6%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.37%).

High Dividend: CLN's dividend (0.6%) is low compared to the top 25% of dividend payers in the Polish market (7.95%).


Earnings Payout to Shareholders

Earnings Coverage: CLN is not paying a notable dividend for the Polish market.


Cash Payout to Shareholders

Cash Flow Coverage: CLN is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.